Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Cyclic AMP is a key regulator of M1 to M2a phenotypic conversion of microglia in the presence of Th2 cytokines.
Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.
Vitamin D as an immune modulator in multiple sclerosis, a review.
Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS.
Capparis ovata treatment suppresses inflammatory cytokine expression and ameliorates experimental allergic encephalomyelitis model of multiple sclerosis in C57BL/6 mice.
The Association between Vascular Endothelial Growth Factor-related Factors with Severity of Multiple Sclerosis.
BMP7 retards peripheral myelination by activating p38 MAPK in Schwann cells.
Genetic modifications associated with ketogenic diet treatment in the BTBR(T+Tf/J) mouse model of autism spectrum disorder.
Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.
Reactive oxygen species in organ-specific autoimmunity.
Disease modifying therapies for relapsing multiple sclerosis.
Consensus opinion of US neurologists on practice patterns in RIS, CIS, and RRMS: Evolution of treatment practices.
Acute axonal damage in three different murine models of multiple sclerosis: a comparative approach.
Reduced fecal GABA levels in multiple sclerosis patients.
Vitamin D level status in Thai neuromyelitis optica patients.
Oligodendrocyte differentiation.
Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies.
Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60.
An update on the causes, assessment and management of third division sensory trigeminal neuropathies.
Soluble BAFF Level Is Not Correlated to Mycobacterium avium Subspecies Paratuberculosis Antibodies and Increases After Interferon-β Therapy in Multiple Sclerosis Patients.
Step-rate cut-points for physical activity intensity in patients with multiple sclerosis: The effect of disability status.
Sphingosine 1-phosphate signaling in astrocytes: Implications for progressive multiple sclerosis.
Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.

Pages